Pangen Biotech Inc.
Develops and manufactures biopharmaceuticals and offers CDMO services.
222110 | KO
Overview
Corporate Details
- ISIN(s):
- KR7222110009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) , 수원시
- Sector:
- Manufacturing
Description
Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-10-12 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 96.7 KB | ||
| 2022-10-12 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 26.7 KB | ||
| 2022-08-22 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 96.1 KB | ||
| 2022-08-22 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 25.3 KB | ||
| 2022-08-22 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 11.1 KB | ||
| 2022-08-22 00:00 |
투자판단관련주요경영사항(빈혈치료제인 에리사(ERYSAA) 필리핀 품목허가 획득)
|
Korean | 6.8 KB | ||
| 2022-08-12 00:00 |
반기보고서 (2022.06)
|
Korean | 1.0 MB | ||
| 2022-06-21 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 101.8 KB | ||
| 2022-06-21 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 26.3 KB | ||
| 2022-05-23 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 25.3 KB | ||
| 2022-05-23 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 96.9 KB | ||
| 2022-05-13 00:00 |
분기보고서 (2022.03)
|
Korean | 1.0 MB | ||
| 2022-03-24 00:00 |
정기주주총회결과
|
Korean | 24.8 KB | ||
| 2022-03-16 00:00 |
사업보고서 (2021.12)
|
Korean | 549.8 KB | ||
| 2022-03-08 00:00 |
주주총회소집공고
|
Korean | 587.8 KB |
Automate Your Workflow. Get a real-time feed of all Pangen Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pangen Biotech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pangen Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
